Development and validation of a risk prediction score for the severity of acute hypertriglyceridemic pancreatitis in Chinese patients

doi:10.3748/wjg.v28.i33.4846

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 33

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5291)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-5) series.

Item

Count

PDF

275

WORD

HTML

3040

Figures (1-5)

313

Tables (1-5)

305

Sum=3995

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

393

Download

903

Sum=1296

Sep 7, 2022 (publication date) through Mar 16, 2025

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Sep 7, 2022; 28(33): 4846-4860
Published online Sep 7, 2022. doi: 10.3748/wjg.v28.i33.4846

Table 1 Demographic and clinical characteristics of patients in the non-severe acute pancreatitis and severe acute pancreatitis groups

Patient characteristics	All (n = 243)	Non-SAP (n = 181)	SAP (n = 62)	P value
Demographic variables
Sex, n (%)				0.297
Male	188 (77.37)	143 (79.00)	45 (72.60)
Female	55 (22.63)	38 (21.00)	17 (27.40)
Age (yr)	40.12 ± 10.12	39.60 ± 10.10	41.60 ± 10.20	0.190
BMI (kg/m²)	28.27 ± 4.25	28.10 ± 4.00	28.70 ± 4.90	0.367
Medical history
Diabetes, n (%)				0.648
Yes	139 (57.20)	102 (56.40)	37 (59.70)
No	104 (42.80)	79 (43.65)	25 (40.30)
Hypertension, n (%)				0.164
Yes	59 (24.28)	48 (26.50)	11 (17.70)
No	184 (75.72)	133 (73.50)	51 (82.30)
Hyperlipidemia, n (%)				0.250
Yes	152 (62.55)	64 (35.40)	27 (43.50)
No	91 (37.45)	64 (35.40)	27 (43.50)
Fatty liver, n (%)				0.073
Yes	185 (76.13)	143 (79.00)	42 (67.70)
No	58 (23.87)	38 (21.00)	20 (32.30)
Drinking, n (%)				0.483
Yes	120 (49.38)	87 (48.10)	33 (53.20)
No	123 (50.62)	94 (51.90)	29 (46.80)
Smoking, n (%)				0.386
Yes	133 (54.73)	102 (56.40)	31 (50.00)
No	110 (45.27)	79 (43.60)	31 (50.00)
Clinical signs
HR (bpm)	96.14 ± 18.17	92.23 ± 16.30	107.58 ± 18.65	< 0.001
R (bpm)	21.66 ± 5.33	20.47 ± 4.38	25.27 ± 6.21	< 0.001
SBP (mmHg)	133.50 ± 17.52	133.51 ± 16.56	133.48 ± 20.21	0.992
DBP (mmHg)	81.13 ± 12.03	80.85 ± 11.28	81.92 ± 14.08	0.548
		Non-SAP (n = 181, 74.49%)	SAP (n = 62, 25.51%)
Laboratory findings
WBC (× 10⁹/L)	12.53 ± 3.86	11.96 ± 3.63	14.41 ± 3.97	< 0.001
NLR	9.94 ± 7.27	8.82 ± 6.98	13.19 ± 7.15	< 0.001
RDW (fL)	12.87 ± 0.72	12.80 ± 0.69	13.08 ± 0.78	0.009
PLT (× 10⁹/L)	218.91 ± 61.98	216.09 ± 57.99	227.15 ± 72.30	0.226
MPV (fL)	10.75 ± 1.05	10.68 ± 1.01	10.95 ± 1.14	0.074
PDW (fL)	12.66 ± 2.22	12.47 ± 2.09	13.23 ± 2.47	0.018
TC (mmol/L)	10.15 ± 4.11	9.54 ± 3.62	11.94 ± 4.92	< 0.001
TG (mmol/L)	21.08 ± 7.50	20.17 ± 7.31	23.75 ± 7.49	0.001
H/L ratio	0.96 ± 1.36	0.96 ± 1.36	0.97 ± 1.36	0.946
ApoA1 (g/L)	1.02 ± 0.35	1.11 ± 0.34	0.75 ± 0.23	< 0.001
TBIL (μmol/L)	14.16 ± 8.29	13.81 ± 7.11	15.16 ± 11.03	0.987
AST (U/L)	29.78 ± 17.41	27.40 ± 13.03	36.76 ± 25.20	< 0.001
ALT (U/L)	31.04 ± 28.70	30.80 ± 29.94	31.73 ± 24.94	0.826
ALP (U/L)	73.91 ± 25.30	73.59 ± 22.70	74.84 ± 31.88	0.737
ALB (g/L)	41.57 ± 5.91	42.22 ± 5.53	39.66 ± 6.58	0.003
BUN mmol/L	4.32 ± 2.03	4.05 ± 1.39	5.10 ± 3.12	< 0.001
Cr (μmol/L)	62.62 ± 42.98	56.64 ± 15.83	80.10 ± 78.56	< 0.001
fT3 (pmol/L)	1.97 ± 0.37	1.99 ± 0.36	1.91 ± 0.41	0.134
CRP (mg/L)	160.20 ± 127.36	133.55 ± 112.64	237.99 ± 136.59	< 0.001
PCT (ng/mL)	0.80 ± 1.93	0.59 ± 1.72	1.42 ± 2.35	0.003
ESR (mm/h)	42.57 ± 24.76	40.71 ± 25.10	47.99 ± 23.06	0.045
Na (mmol/L)	133.97 ± 4.29	134.28 ± 4.09	133.07 ± 4.76	0.054
K (mmol/L)	4.02 ± 0.46	3.97 ± 0.35	4.19 ± 0.67	0.080
Ca²⁺(mmol/L)	2.13 ± 0.26	2.19 ± 0.18	1.96 ± 0.36	< 0.001
PT (s)	13.26 ± 0.98	13.12 ± 0.84	13.68 ± 1.21	< 0.001
APTT (s)	37.82 ± 5.28	37.35 ± 5.14	39.22 ± 5.45	0.016
TT (s)	15.07 ± 1.10	15.08 ± 1.09	15.05 ± 1.13	0.823
FIB (g/L)	5.70 ± 2.21	5.41 ± 2.10	6.56 ± 2.32	< 0.001
D-dimer (μg/L)	1.34 ± 1.83	0.94 ± 0.98	2.51 ± 2.94	< 0.001
Imaging results
Pleural effusion, n (%)				< 0.001
Yes	69 (28.40)	23 (12.71)	46 (74.19)
No	174 (71.61)	158 (87.30)	16 (25.81)

BMI: Body mass index; RR: Respiratory rate; HR: Heart rate; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; SAP: Severe acute pancreatitis; Non-SAP: Mild acute pancreatitis and moderately sever acute pancreatitis; WBC: White blood cell; NLR: Neutrophil to lymphocyte ratio; RDW: Red blood cell distribution width; PLT: Platelet counts; RDW: MPV Mean platelet volume; PDW: Platelet distribution width; TC: Total cholesterol; TG: Triglyceride; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; ApoA1: Apolipoprotein A1; TBIL: Total bilirubin; AST: Aspartate transaminase; ALT: Alanine aminotransferase; ALP: Alkaline phosphatase; ALB: Albumin; BUN: Blood urea nitrogen; Cr: Creatinine; fT3: Free triiodothyronine; CRP: C-reactive protein; PCT: Procalcitonin; Na: Sodium; K: Potassium; Ca²⁺: Calcium; PT: Prothrombin time; APTT: Activated partial thromboplastin time; TT: Thrombin time; FIB: Fibrinogen; SAP: Severe acute pancreatitis; Non-SAP: Mild acute pancreatitis and moderately sever acute pancreatitis.

Table 2 Univariable and multivariable logistic regression analyses of predictive factors for severe acute pancreatitis in all subjects

Variables	Univariable regression		Multivariable regression
Variables	OR (95%CI)	P value	OR (95%CI)	P value
Age	1.02 (0.99-1.05)	0.190	1.07 (1.01-1.14)	0.033
BMI (kg/m²)	1.03 (0.96-1.10)	0.366	1.08 (0.94-1.24)	0.278
Hypertension
No	1.00		1.00
Yes	0.60 (0.29-1.24)	0.167	1.02 (0.99-1.06)	0.201
Diabetes
No	1.00		1.00
Yes	1.15 (0.64-2.06)	0.648	1.27 (0.38-4.24)	0.693
HR (bpm)	1.05 (1.03-1.07)	< 0.0001	1.02 (0.99-1.06)	0.201
RR (bpm)	1.20 (1.12-1.28)	< 0.0001	1.12 (0.99-1.26)	0.068
TG (mmol/L)
< 11.3	1.00		1.00
11.3-22.6	2.06 (0.57-7.49)	0.273	4.20 (0.40-44.25)	0.232
≥ 22.6	3.43 (0.96-12.20)	0.057	5.95 (0.56-62.75)	0.138
ApoA1 (g/L)	0.01 (0.00-0.05)	< 0.0001	0.02 (0.00-0.12)	< 0.0001
Cr (μmol/L)	1.02 (1.01-1.03)	0.002	1.01 (0.99-1.02)	0.458
Bun (μmol/L)	1.27 (1.10-1.48)	0.001	1.29 (0.92-1.81)	0.145
WBC (× 10⁹/L)	1.18 (1.09-1.28)	< 0.0001	1.08 (0.95-1.24)	0.248
Ca²⁺ (mmol/L)	0.02 (0.01-0.09)	< 0.0001	0.11 (0.01-1.02)	0.040
D-dimer (μg/L)	1.69 (1.35-2.12)	< 0.0001	1.24 (0.94-1.63)	0.122
Pleural effusion	19.75 (9.64-40.48)	< 0.0001	15.62 (5.05-48.24)	< 0.0001

BMI: Body mass index; RR: Respiratory rate; HR: Heart rate; SBP: Systolic blood pressure; WBC: White blood cell; ApoA1: Apolipoprotein A1; BUN: Blood urea nitrogen; Cr: Creatinine; Ca: Calcium; SAP: Severe acute pancreatitis; OR: Odds ratio.

Table 3 Comparison of diagnostic performance for predicting severe acute pancreatitis between the AAP and other existing clinical scores

Variables	ΔAUC	95%CI	Z statistic	P value
AAP-APACHE II	0.122	0.057-0.187	3.661	0.000
AAP-BISAP	0.076	0.007-0.198	3.839	0.000
AAP-MCTSI	0.098	0.027-0.305	3.111	0.002
AAP-Ranson	0.104	0.048-0.159	3.670	0.000
AAP-EASY	0.122	0.056-0.188	3.606	0.000

AAP: Our risk prediction score referred to as AAP; EASY: EASY prediction score; ΔAUC: Difference of areas under curve between AAP and other clinical scores; SE: Standard error; CI: Confidence interval; SAP: Severe acute pancreatitis.

Table 4 Diagnostic performance of the integrated discrimination improvement between the AAP and other clinical scores

Variables	IDI	SE	95%CI	Z statistic	P value
AAP-APACHE-II	0.201	0.077	0.050-0.352	2.601	0.009
AAP-BISAP	0.095	0.052	0.037-0.115	1.828	0.068
AAP-MCTSI	0.166	0.071	0.036-0.160	2.339	0.019
AAP-Ranson	0.216	0.063	0.093-0.338	3.444	0.001
AAP-EASY	0.205	0.082	0.045-0.365	2.513	0.012

IDI: Integrated discrimination improvement; SE: Standard error; CI: Confidence interval; AAP: Our risk prediction score referred to as AAP; EASY: EASY prediction score; SAP: Severe acute pancreatitis.

Table 5 The relationship between risk stratification and clinical parameters

	Low-risk group (n = 158)		High-risk group (n = 85)	P value
Local complications
APFC	43 (27.22%)	68 (80.00%)		< 0.001
PPC	3 (1.90%)	10 (11.77%)		0.001
ANC	3 (1.90%)	22 (25.88%)		< 0.001
WON	0 (0.00%)	4 (4.71%)		0.014
Systemic complications
SIRS	92 (58.23%)	72 (84.71%)		< 0.001
Respiratory failure	29 (18.35%)	59 (69.41%)		< 0.001
Renal failure	0 (0.00%)	13 (15.29%)		< 0.001
Cardiovascular failure	2 (1.27%)	5 (5.88%)		0.040
Clinical Scoring Systems
Ranson ≥ 3	28 (17.72%)	53 (62.35%)		< 0.001
BISAP ≥ 3	0 (0.00%)	4 (4.71%)		0.014
MCTSI ≥ 4	15 (9.49%)	53 (62.35%)		< 0.001
APACHE-II ≥ 8	73 (46.20%)	68 (80.00%)		< 0.001
CRP ≥ 190	42 (26.58%)	44 (51.77%)		< 0.001
Hospital day, days	13.51 ± 5.45	20.04 ± 8.14		< 0.001

APFC: Acute peripancreatic fluid collection; PPC: Pancreatic pseudocyst; ANC: Acute necrotic collection; WON: Walled-off necrosis; IPN: Infected pancreatic necrosis; SIRS: Systemic inflammatory response syndrome.

Citation: Liu ZY, Tian L, Sun XY, Liu ZS, Hao LJ, Shen WW, Gao YQ, Zhai HH. Development and validation of a risk prediction score for the severity of acute hypertriglyceridemic pancreatitis in Chinese patients. World J Gastroenterol 2022; 28(33): 4846-4860
URL: https://www.wjgnet.com/1007-9327/full/v28/i33/4846.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i33.4846